Calotropis procera latex-induced inflammatory hyperalgesia - Effect of antiinflammatory drugs

Mediators of Inflammation

Volumn 2005, Issue 4, 2005, Pages 216-220

  Sehgal, Raman ^a   Kumar, Vijay L ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CALOTROPIS PROCERA EXTRACT; CYPROHEPTADINE; DICLOFENAC; ROFECOXIB; SEROTONIN ANTAGONIST;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLIMBING; COMPRESSION; CONTROLLED STUDY; DRUG SCREENING; EDEMA; FUNCTIONAL DISEASE; GROOMING; HYPERALGESIA; INFLAMMATION; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PAW EDEMA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; CALOTROPIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HISTAMINE; HYPERALGESIA; INFLAMMATION; LATEX; MALE; PROSTAGLANDINS; RATS; RATS, WISTAR;

CALOTROPIS PROCERA;

EID: 25644433389     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI.2005.216     Document Type: Article

References (26)

1. CSIR Publication and Information Directorate. Wealth of India: Raw materials. III. New Delhi, India: CSIR Publication and Information Directorate; 1992;78-84.
2. Mahmoud OM, Adam SE, Tartour G. The effects of Calotropis procera on small ruminants II. Effects of administration of the latex to sheep and goats. J Comp Pathol. 1979;89(2):251-263.
3. Kumar VL, Arya S. Medicinal uses and pharmacological properties of Calotropis procera. Recent Prog Med Plants. In press.
4. Majumder PK, Kumar VL. Anti-inflammatory activity of fractions of latex of Calotropis procera in carrageenin induced paw oedema. Phytother Res. 1997;11:166-167.
5. Dewan S, Sangraula H, Kumar VL. Preliminary studies on the analgesic activity of the latex of Calotropis procera. J Ethnopharmacol. 2000;73(1-2):307-311.
6. Dewan S, Kumar S, Kumar VL. Antipyretic effect of latex of Calotropis procera. Ind J Pharmacol. 2000;32(3):252.
7. Singh H, Kumar S, Dewan S, Kumar VL. Inflammation induced by latex of Calotropis procera-a new model to evaluate anti-inflammatory drugs. J Pharmacol Toxicol Methods. 2000;43(3):219-224.
8. Handa F, Sadana JK, Sharma PK. Allergic contact dermatitis due to the plant of Calotropis procera (Vern: AK). A case report. Ind J Dermatol. 1984;29(3):27-29.
9. Al-Mezaine HS, Al-Rajhi AA, Al-Assiri A, Wagoner MD. Calotropis procera (ushaar) keratitis. Am J Ophthalmol. 2005;139(1):199-202.
10. Biedner B, Rothko. L,Witzium A. Calotropis procera (Sodom apple) latex keratoconjunctivitis. Isr J Med Sci. 1977;13(9):914-916.
11. Shivkar YM, Kumar VL. Histamine mediates the pro-inflammatory effect of latex of Calotropis procera in rats. Mediators Inflamm. 2003;12(5):299-302.
12. Kumar VL, Shivkar YM. Involvement of prostaglandins in inflammation induced by latex of Calotropis procera. Mediators Inflamm. 2004;13(3):151-155.
13. Di Rosa M, Giroud JP, Willoughby DA. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971;104(1):15-29.
14. Guay J, Bateman K, Gordon R, Mancini J, Riendeau D. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem. 2004;279(23):24866-24872.
15. Juan H. Dependence of histamine-evoked nociception on prostaglandin release. Agents Actions. 1981;11(6-7):706-710.
16. Ferreira SH. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 1993;46(1):1-9.
17. Harris RR, Black L, Surapaneni S, et al. ABT-963[2-(3,4-difluoro-phenyl)- 4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor. J Pharmacol Exp Ther. 2004;311(3):904-912.
18. De Campos RO, Alves RV, Kyle DJ, Chakravarty S, Mavunkel BJ, Calixto JB. Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist. Eur J Pharmacol. 1996;316(2-3):277-286.
19. Lomen PL, Turner LF, Lamborn KR, Brinn EL, Sattler LP . Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone. Am J Med. 1986;80(3A):120-126.
20. De Castro Costa M, De Sutter P, Gybels J, Van Hees J. Adjuvant-induced arthritis in rats: a possible animal model of chronic pain. Pain. 1981;10(2):173-186.
21. Wang Y, Huang C, Cao Y, Han JS. Repeated administration of low dose ketamine for the treatment of monoarthritic pain in the rat. Life Sci. 2000;67(3):261-267.
22. Capasso F, Dunn CJ, Yamamoto S, Willoughby DA, Giroud JP. Further studies on carrageenan-induced pleurisy in rats. J Pathol. 1975;116(2):117-124.
23. Reylon V, Siddiqui HH. Anti-spasmogenic effect of cyproheptadine on guinea-pig ileum. Indian J Physiol Pharmacol. 1983;27(4):342-344.
24. Desjardins PJ, Black PM, Daniels S, et al. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin. 2004;20(10):1523-1537.
25. Francischi JN, Chaves CT, Moura AC, et al. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol. 2002;137(6):837-844.
26. Burian M, Tegeder I, Seegel M, Geisslinger G. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin Pharmacol Ther. 2003;74(2):113-120.